# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://www.agilonhealth.com/news/press-release/agilon-health-announces-partnership-with-eagle-physicians-a-leading-multi-speci...
Deutsche Bank analyst George Hill maintains Agilon Health (NYSE:AGL) with a Hold and lowers the price target from $5 to $4.
Benchmark analyst Bill Sutherland reiterates Agilon Health (NYSE:AGL) with a Buy and maintains $9 price target.
RBC Capital analyst Sean Dodge reiterates Agilon Health (NYSE:AGL) with a Outperform and maintains $8 price target.
Agilon Health (NYSE:AGL) reported quarterly sales of $1.483 billion which missed the analyst consensus estimate of $1.560 billi...